A Study of Belantamab Mafodotin in Multiple Myeloma Participants With Normal and Impaired Hepatic Function
Clinical trial NCT04398680 · WITHDRAWN
Trial details
- NCT number
- NCT04398680
- Sponsor
- GlaxoSmithKline
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-20
- Primary completion
- 2025-11-04
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.